Bayer's Nexavar Gets U.S. FDA Approval for Liver Cancer

Bayer AG said it has received approval from the U.S. Food and Drug Administration for use of Nexavar tablets to fight HCC, the most common form of liver cancer, the second approval for the new use after it was cleared in Europe last month.
ABCMoney.co.uk